Skip to main navigation Skip to search Skip to main content

Survivin mRNA antagonists using locked nucleic acid, potential for molecular cancer therapy

  • Niels Fisker
  • , Majken Westergaard
  • , Henrik Frydenlund Hansen
  • , Jens Bo Hansen
  • Santaris Pharma A/S, Hørsholm

Research output: Contribution to journal › Journal article › Research › peer-review

Fingerprint

Dive into the research topics of 'Survivin mRNA antagonists using locked nucleic acid, potential for molecular cancer therapy'. Together they form a unique fingerprint.
Sort by

Neuroscience